Gut Microbiota in Colorectal Cancer: Biological Role and Therapeutic Opportunities

Overview

Journal Cancers (Basel)

Publisher MDPI

Specialty Oncology

Date 2023 Feb 11

PMID 36765824

Authors

Himani Pandey

Daryl W T Tang

Sunny H Wong

Devi Lal

Affiliations

Soon will be listed here.

Abstract

Colorectal cancer (CRC) is the second-leading cause of cancer-related deaths worldwide. While CRC is thought to be an interplay between genetic and environmental factors, several lines of evidence suggest the involvement of gut microbiota in promoting inflammation and tumor progression. Gut microbiota refer to the ~40 trillion microorganisms that inhabit the human gut. Advances in next-generation sequencing technologies and metagenomics have provided new insights into the gut microbial ecology and have helped in linking gut microbiota to CRC. Many studies carried out in humans and animal models have emphasized the role of certain gut bacteria, such as , enterotoxigenic , and colibactin-producing , in the onset and progression of CRC. Metagenomic studies have opened up new avenues for the application of gut microbiota in the diagnosis, prevention, and treatment of CRC. This review article summarizes the role of gut microbiota in CRC development and its use as a biomarker to predict the disease and its potential therapeutic applications.

Citing Articles

Advances in gut microbiota-related treatment strategies for managing colorectal cancer in humans.

Roy B, Cao K, Singh C, Fang X, Yang H, Wei D Cancer Biol Med. 2025; 22(2).

PMID: 40072039 PMC: 11899591. DOI: 10.20892/j.issn.2095-3941.2024.0263.

CircRNAs in Colorectal Cancer: Unveiling Their Roles and Exploring Therapeutic Potential.

Ding Y, Song X, Chen J Biochem Genet. 2025; .

PMID: 40029586 DOI: 10.1007/s10528-025-11068-5.

promotes tumor progression via the Integrin α2/β1-PI3K-AKT-mTOR-C-myc signaling pathway in colorectal cancer.

Chen Y, Qin Y, Fan T, Qiu C, Zhang Y, Dai M Int J Biol Sci. 2025; 21(4):1497-1512.

PMID: 39990665 PMC: 11844286. DOI: 10.7150/ijbs.102742.

Helminths in alternative therapeutics of inflammatory bowel disease.

Pandey H, Tang D, Wong S, Lal D Intest Res. 2025; 23(1):8-22.

PMID: 39916482 PMC: 11834367. DOI: 10.5217/ir.2023.00059.

Impact of antibiotic prophylaxis on gut microbiota in colorectal surgery: insights from an Eastern European stewardship study.

Vacarean-Trandafir I, Amarandi R, Ivanov I, Dragos L, Mentel M, Iacob S Front Cell Infect Microbiol. 2025; 14:1468645.

PMID: 39872941 PMC: 11770057. DOI: 10.3389/fcimb.2024.1468645.

References

Higashimura Y, Naito Y, Takagi T, Uchiyama K, Mizushima K, Ushiroda C . Protective effect of agaro-oligosaccharides on gut dysbiosis and colon tumorigenesis in high-fat diet-fed mice. Am J Physiol Gastrointest Liver Physiol. 2016; 310(6):G367-75. DOI: 10.1152/ajpgi.00324.2015. View

Feng Q, Liang S, Jia H, Stadlmayr A, Tang L, Lan Z . Gut microbiome development along the colorectal adenoma-carcinoma sequence. Nat Commun. 2015; 6:6528. DOI: 10.1038/ncomms7528. View

Windey K, De Preter V, Verbeke K . Relevance of protein fermentation to gut health. Mol Nutr Food Res. 2011; 56(1):184-96. DOI: 10.1002/mnfr.201100542. View

Quera R, Espinoza R, Estay C, Rivera D . Bacteremia as an adverse event of fecal microbiota transplantation in a patient with Crohn's disease and recurrent Clostridium difficile infection. J Crohns Colitis. 2013; 8(3):252-3. DOI: 10.1016/j.crohns.2013.10.002. View

Tsoi H, Chu E, Zhang X, Sheng J, Nakatsu G, Ng S . Peptostreptococcus anaerobius Induces Intracellular Cholesterol Biosynthesis in Colon Cells to Induce Proliferation and Causes Dysplasia in Mice. Gastroenterology. 2017; 152(6):1419-1433.e5. DOI: 10.1053/j.gastro.2017.01.009. View

Ridaura V, Faith J, Rey F, Cheng J, Duncan A, Kau A . Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science. 2013; 341(6150):1241214. PMC: 3829625. DOI: 10.1126/science.1241214. View

Weijenberg M, Luchtenborg M, de Goeij A, Brink M, van Muijen G, de Bruine A . Dietary fat and risk of colon and rectal cancer with aberrant MLH1 expression, APC or KRAS genes. Cancer Causes Control. 2007; 18(8):865-79. PMC: 2039842. DOI: 10.1007/s10552-007-9032-6. View

Sokol H, Leducq V, Aschard H, Pham H, Jegou S, Landman C . Fungal microbiota dysbiosis in IBD. Gut. 2016; 66(6):1039-1048. PMC: 5532459. DOI: 10.1136/gutjnl-2015-310746. View

Shaw S, Berry S, Thomson J, Murray G, El-Omar E, Hold G . Gut Mucosal Microbiome Signatures of Colorectal Cancer Differ According to BMI Status. Front Med (Lausanne). 2022; 8:800566. PMC: 8861504. DOI: 10.3389/fmed.2021.800566. View

10.

Jalandra R, Dalal N, Yadav A, Verma D, Sharma M, Singh R . Emerging role of trimethylamine-N-oxide (TMAO) in colorectal cancer. Appl Microbiol Biotechnol. 2021; 105(20):7651-7660. DOI: 10.1007/s00253-021-11582-7. View

11.

Moreno V, Gemignani F, Landi S, Gioia-Patricola L, Chabrier A, Blanco I . Polymorphisms in genes of nucleotide and base excision repair: risk and prognosis of colorectal cancer. Clin Cancer Res. 2006; 12(7 Pt 1):2101-8. DOI: 10.1158/1078-0432.CCR-05-1363. View

12.

Macfarlane S, Woodmansey E, Macfarlane G . Colonization of mucin by human intestinal bacteria and establishment of biofilm communities in a two-stage continuous culture system. Appl Environ Microbiol. 2005; 71(11):7483-92. PMC: 1287682. DOI: 10.1128/AEM.71.11.7483-7492.2005. View

13.

Augenlicht L, Mariadason J, Wilson A, Arango D, Yang W, Heerdt B . Short chain fatty acids and colon cancer. J Nutr. 2002; 132(12):3804S-3808S. DOI: 10.1093/jn/132.12.3804S. View

14.

Illescas O, Rodriguez-Sosa M, Gariboldi M . Mediterranean Diet to Prevent the Development of Colon Diseases: A Meta-Analysis of Gut Microbiota Studies. Nutrients. 2021; 13(7). PMC: 8308215. DOI: 10.3390/nu13072234. View

15.

Dvorak K, Payne C, Chavarria M, Ramsey L, Dvorakova B, Bernstein H . Bile acids in combination with low pH induce oxidative stress and oxidative DNA damage: relevance to the pathogenesis of Barrett's oesophagus. Gut. 2006; 56(6):763-71. PMC: 1954874. DOI: 10.1136/gut.2006.103697. View

16.

Sharma M, Li L, Celver J, Killian C, Kovoor A, Seeram N . Effects of fruit ellagitannin extracts, ellagic acid, and their colonic metabolite, urolithin A, on Wnt signaling. J Agric Food Chem. 2009; 58(7):3965-9. PMC: 2850963. DOI: 10.1021/jf902857v. View

17.

Carmody R, Gerber G, Luevano Jr J, Gatti D, Somes L, Svenson K . Diet dominates host genotype in shaping the murine gut microbiota. Cell Host Microbe. 2014; 17(1):72-84. PMC: 4297240. DOI: 10.1016/j.chom.2014.11.010. View

18.

Yan X, Liu L, Li H, Qin H, Sun Z . Clinical significance of , epithelial-mesenchymal transition, and cancer stem cell markers in stage III/IV colorectal cancer patients. Onco Targets Ther. 2017; 10:5031-5046. PMC: 5652912. DOI: 10.2147/OTT.S145949. View

19.

Peterson L, Artis D . Intestinal epithelial cells: regulators of barrier function and immune homeostasis. Nat Rev Immunol. 2014; 14(3):141-53. DOI: 10.1038/nri3608. View

20.

Cross A, Ferrucci L, Risch A, Graubard B, Ward M, Park Y . A large prospective study of meat consumption and colorectal cancer risk: an investigation of potential mechanisms underlying this association. Cancer Res. 2010; 70(6):2406-14. PMC: 2840051. DOI: 10.1158/0008-5472.CAN-09-3929. View